XML 81 R56.htm IDEA: XBRL DOCUMENT
v3.22.4

Capital Management (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2022
Corporate Information And Statement Of IFRS Compliance [Abstract] |
Schedule of total capital | For regulatory reporting purposes under the LICAT framework, there were further adjustments, including goodwill, non-life investments, and others as prescribed by OSFI, to the total capital figure presented in the table below:
As at December 31, | 2022 | 2021
Subordinated debt |  | $ | 6,676 |  |  | $ | 6,425 |
Innovative capital instruments(1) |  | 200 |  |  | 200 |
Equity: |  |  |  |
Preferred shares and other equity instruments |  | 2,239 |  |  | 2,239 |
Common shareholders’ equity(2) |  | 25,211 |  |  | 24,075 |
Participating policyholders’ equity |  | 1,837 |  |  | 1,700 |
Non-controlling interests’ equity |  | 90 |  |  | 59 |
Total capital |  | $ | 36,253 |  |  | $ | 34,698 |
(1) Innovative capital instruments are SLEECS issued by SLCT I (Note 13). SLCT I is not consolidated by us. (2) Common shareholders' equity is equal to Total shareholders' equity less Preferred shares and other equity instruments

X
- Definition Corporate Information And Statement Of IFRS Compliance [Abstract] + References No definition available. + Details
Name: | slf_CorporateInformationAndStatementOfIFRSComplianceAbstract
Namespace Prefix: | slf_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure Of Total Capital [Table Text Block] + References No definition available. + Details
Name: | slf_DisclosureOfTotalCapitalTableTextBlock
Namespace Prefix: | slf_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration